- Report
- November 2023
- 30 Pages
Global
From €2462EUR$2,750USD£2,097GBP
- Report
- November 2023
- 30 Pages
Global
From €2462EUR$2,750USD£2,097GBP
- Report
- November 2023
- 30 Pages
Global
From €2462EUR$2,750USD£2,097GBP
- Report
- November 2023
- 30 Pages
Global
From €2462EUR$2,750USD£2,097GBP
- Report
- November 2023
- 30 Pages
Global
From €2909EUR$3,250USD£2,478GBP
- Report
- January 2022
- 60 Pages
Global
From €1343EUR$1,500USD£1,144GBP
- Report
- January 2022
- 60 Pages
Global
From €1343EUR$1,500USD£1,144GBP
- Report
- January 2022
- 60 Pages
Global
From €1343EUR$1,500USD£1,144GBP
- Report
- January 2022
- 60 Pages
Global
From €1790EUR$2,000USD£1,525GBP
- Report
- January 2022
- 60 Pages
Global
From €1343EUR$1,500USD£1,144GBP
- Report
- January 2025
- 73 Pages
From €3088EUR$3,450USD£2,631GBP
- Report
- July 2024
- 91 Pages
From €3088EUR$3,450USD£2,631GBP
- Report
- May 2024
- 113 Pages
Europe
From €3088EUR$3,450USD£2,631GBP
- Report
- May 2024
- 117 Pages
Asia Pacific
From €3088EUR$3,450USD£2,631GBP
- Report
- May 2024
- 95 Pages
North America
From €3088EUR$3,450USD£2,631GBP
- Report
- May 2024
- 100 Pages
Africa, Middle East
From €3088EUR$3,450USD£2,631GBP
- Report
- May 2024
- 95 Pages
From €3088EUR$3,450USD£2,631GBP
- Report
- April 2024
- 71 Pages
Europe
From €3088EUR$3,450USD£2,631GBP
- Report
- April 2024
- 68 Pages
North America
From €3088EUR$3,450USD£2,631GBP
- Report
- March 2024
- 150 Pages
Global
From €3984EUR$4,450USD£3,393GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more